Stay updated with breaking news from Study Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
26.03.2024 - TORONTO, ON / ACCESSWIRE / March 26, 2024 / Theralase Technologies Inc. ('Theralase' or the 'Company') (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic ... Seite 1
Theralase(R) to Host Advisory Board Meetings at Canadian Urological ...
In the Performance to Primary, Secondary and Tertiary Objectives second table the 90 day results were misstated and has been corrected in this press release.TORONTO, ON / ACCESSWIRE / May 30, 2023 / Theralase®
TORONTO, ON / ACCESSWIRE / May 30 2023 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development
Theralase Provides Update on Phase II Bladder Cancer Study